Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Fallopian Tube Neoplasms 9 Ovarian Neoplasms 8 Uterine Cervical Neoplasms 6 Pancreatic Neoplasms 4 Brenner Tumor 4 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Thymoma 2 Testicular Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Salivary Gland Neoplasms 2 Oropharyngeal Neoplasms 2 Neurotoxicity Syndromes 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 HIV Infections 2 Esophageal Neoplasms 2 Endometrial Clear Cell Adenocarcinoma 2 Endometrial Adenocarcinoma 2 Carcinoma, Ovarian Epithelial 2 Anus Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 2 Urinary Bladder Neoplasms 1 Teratoma, Testicular 1 Teratoma, Ovarian 1 Teratoma 1 Sertoli-Leydig Cell Tumor 1

Interventions

Fluorouracil 6 Cisplatin 4 Radiotherapy 3 Mitomycin 3 dehydroftorafur 2 Radiotherapy, Intensity-Modulated 2 Cetuximab 2 Capecitabine 2 Taxes 1 Specimen Handling 1 Platinum 1 Paclitaxel 1 Mitozytrex 1 Magnetic Resonance Spectroscopy 1 Fluorodeoxyglucose F18 1 Carboplatin 1 Biopsy 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Anal Canal Carcinoma × Taxes × Clear all

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡